CC
Caxton Corporation Portfolio holdings
AUM
$9.85M
This Quarter Return
+35.68%
1 Year Return
+26.35%
3 Year Return
+409.06%
5 Year Return
+527.59%
10 Year Return
+11,054.45%
AUM
$108M
AUM Growth
+$108M
(+31%)
Cap. Flow
+$4.79M
Cap. Flow
% of AUM
4.45%
Top 10 Holdings %
Top 10 Hldgs %
93.85%
Holding
31
New
6
Increased
10
Reduced
5
Closed
5
Top Buys
| 1 |
ABDC
Alcentra Capital Corp
ABDC
|
$5.44M |
| 2 |
KALA BIO
KALA
|
$1.19M |
| 3 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
$337K |
| 4 |
FerroAtlántica
GSM
|
$285K |
| 5 |
Mercado Libre
MELI
|
$221K |
Top Sells
| 1 |
Investcorp Credit Management BDC
ICMB
|
$1.27M |
| 2 |
JBGS
JBG SMITH
JBGS
|
$778K |
| 3 |
Aclaris Therapeutics
ACRS
|
$453K |
| 4 |
Indaptus Therapeutics
INDP
|
$318K |
| 5 |
Ares Capital
ARCC
|
$273K |
Sector Composition
| 1 | Healthcare | 69.43% |
| 2 | Financials | 8.02% |
| 3 | Materials | 0.26% |
| 4 | Technology | 0.23% |
| 5 | Consumer Discretionary | 0.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBBP
1
DELISTED
Strongbridge Biopharma plc.
SBBP
| $32.9M | 30.56% | 6,612,065 +8,000 | +0.1% | +$39.8K |
|
|
2
KALA BIO
KALA
$78.8M
| $12.4M | 11.52% | 1,501,272 +143,633 | +11% | +$1.19M |
|
3
MEI Pharma
MEIP
$160M
| $10.6M | 9.85% | 3,459,124 | – | – |
|
|
MTEM
4
DELISTED
Molecular Templates, Inc.
MTEM
| $9.44M | 8.76% | 1,624,241 | – | – |
|
|
GARS
5
DELISTED
Garrison Capital Inc.
GARS
| $8.8M | 8.16% | 1,225,096 +7,374 | +0.6% | +$52.9K |
|
6
SCYNEXIS
SCYX
$34.9M
| $6.53M | 6.06% | 4,325,000 | – | – |
|
|
7
Investcorp Credit Management BDC
ICMB
$42.6M
| $6.32M | 5.87% | 856,673 -171,682 | -17% | -$1.27M |
|
|
ABDC
8
DELISTED
Alcentra Capital Corp
ABDC
| $6M | 5.57% | 800,000 +724,697 | +962% | +$5.44M |
|
9
Alerian MLP ETF
AMLP
$10.7B
| $4.13M | 3.83% | 411,892 +19 | +0% | +$191 |
|
10
SPDR S&P 500 ETF Trust
SPY
$658B
| $3.96M | 3.67% | 14,010 | – | – |
|
11
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.87M | 1.74% | 9,312 | – | – |
|
|
ARQL
12
DELISTED
Arqule Inc
ARQL
| $700K | 0.65% | 146,066 +21,631 | +17% | +$104K |
|
|
EIGR
13
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $689K | 0.64% | 49,285 +5,576 | +13% | +$78K |
|
|
VIRX
14
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $337K | 0.31% | +277,245 | New | +$337K |
|
15
Kura Oncology
KURA
$686M
| $320K | 0.3% | 19,274 -13,554 | -41% | -$225K |
|
|
CTIC
16
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $313K | 0.29% | 323,026 +199,085 | +161% | +$193K |
|
|
17
FerroAtlántica
GSM
$780M
| $285K | 0.26% | +139,226 | New | +$285K |
|
18
Marker Therapeutics
MRKR
$12M
| $280K | 0.26% | 42,374 -10,955 | -21% | -$72.4K |
|
|
GB
19
DELISTED
Global Blue Group Holding
GB
| $253K | 0.23% | 25,453 -1,663 | -6% | -$16.5K |
|
|
FSTX
20
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $249K | 0.23% | 23,717 +2,683 | +13% | +$28.2K |
|
21
FS KKR Capital
FSK
$5.11B
| $245K | 0.23% | 40,458 -40,890 | -50% | -$248K |
|
|
DRNA
22
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $230K | 0.21% | 15,727 +1,779 | +13% | +$26K |
|
|
23
Mercado Libre
MELI
$125B
| $221K | 0.21% | +435 | New | +$221K |
|
24
American Tower
AMT
$95.5B
| $216K | 0.2% | +1,097 | New | +$216K |
|
25
Credit Acceptance
CACC
$5.78B
| $208K | 0.19% | +460 | New | +$208K |
|